Impact of long-term acyclovir on cytomegalovirus infection and survival after allogeneic bone marrow transplantation
- 1 March 1994
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 343 (8900) , 749-753
- https://doi.org/10.1016/s0140-6736(94)91835-x
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Treatment of Interstitial Pneumonitis Due to Cytomegalovirus with Ganciclovir and Intravenous Immune Globulin: Experience of European Bone Marrow Transplant GroupClinical Infectious Diseases, 1992
- A Randomized, Placebo-Controlled Trial of Oral Acyclovir for the Prevention of Cytomegalovirus Disease in Recipients of Renal AllograftsNew England Journal of Medicine, 1989
- GANCICLOVIR/IMMUNOGLOBULIN COMBINATION THERAPY FOR THE TREATMENT OF HUMAN CYTOMEGALOVIRUS-ASSOCIATED INTERSTITIAL PNEUMONIA IN BONE MARROW ALLOGRAFT RECIPIENTSTransplantation, 1988
- Acyclovir-induced renal failureThe American Journal of Medicine, 1988
- Acyclovir for Prevention of Cytomegalovirus Infection and Disease after Allogeneic Marrow TransplantationNew England Journal of Medicine, 1988
- Incidence and prognosis of cytomegalovirus infections following allogenic bone marrow transplantationJournal of Medical Virology, 1987
- Treatment of Varicella–Zoster Virus Infection in Severely Immunocompromised PatientsNew England Journal of Medicine, 1986
- FASTER IMMUNOLOGICAL RECOVERY AFTER BONE MARROW TRANSPLANTATION IN PATIENTS WITHOUT CYTOMEGALOVIRUS INFECTIONTransplantation, 1985
- Acyclovir Prophylaxis of Herpes-Simplex-Virus InfectionsNew England Journal of Medicine, 1981
- The in vitro activity of Acyclovir and related compounds against cytomegalovirus infectionsJournal of Antimicrobial Chemotherapy, 1981